Short Interest Declines 22.3% For PMC

The most recent short interest data has been released by the NASDAQ for the 05/15/2015 settlement date, which shows a 356,588 share decrease in total short interest for PharMerica Corp ( PMC), to 1,239,538, a decrease of 22.34% since 04/30/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days (at the average volume) it would take to close out all of the open short positions if every share traded represented a short position being closed. Average daily volume for PMC at the 05/15/2015 settlement increased to 372,903, as compared to 283,849 at the 04/30/2015 report. That brought "days to cover" down to 3.32, a 40.89% decrease from the 5.62 days to cover calculated at the previous short interest data release.

The below chart shows the historical "days to cover" for PMC at previous short interest release dates:

Top 25 S.A.F.E. Dividend Stocks »

A decreased "days to cover" value could indicate that short sellers are no longer expecting the same decline in stock price they once were, or it could also indicate a long bet elsewhere was closed where PMC had been shorted as a hedge.

The chart below shows the one year performance of PMC shares, versus its 200 day moving average. Looking at this chart, PMC's low point in its 52 week range is $19.42 per share, with $33.895 as the 52 week high point — that compares with a last trade of $33.40.

If you liked this article you might like

Private Briefing: KKR's Healthcare Deal Spree

Walgreens Takes Piece of PharMerica, Quest to Dominate Healthcare Continues

Magellan Shares Up Strong After Shelling Out $400M to Buy Senior Whole Health

13 Things Kentucky Is Best Known for Other Than the Kentucky Derby

PharMerica (PMC) Stock Soars, Exploring Possible Sale